Picture of Charles River Laboratories International logo

CRL Charles River Laboratories International Cashflow Statement

0.000.00%
us flag iconLast trade - 00:00
HealthcareBalancedLarge CapHigh Flyer

Annual cashflow statement for Charles River Laboratories International, fiscal year end - December 27th, USD millions except per share, conversion factor applied.

2021
December 25th
2022
December 31st
2023
December 30th
2024
December 28th
2025
December 27th
Period Length:12 M12 M12 M12 M12 M
Source:10-K10-K10-K10-K10-K
Standards:
USG
USG
USG
USG
USG
Status:FinalFinalFinalFinalFinal
Net Income/Starting Line39949348025.3-142
Depreciation
Deferred Taxes
Non-Cash Items77.511.642.7445538
Unusual Items
Other Non-Cash Items
Changes in Working Capital42.9-153-102-30.314.1
Change in Accounts Receivable
Change in Inventories
Change in Accounts Payable
Change in Accrued Expenses
Change in Other Liabilities
Net Change in Other Assets & Liabilities
Cash from Operating Activities761620684735738
Capital Expenditures-229-325-319-233-219
Purchase of Fixed Assets
Other Investing Cash Flow Items-1,209-283-245-12.19.83
Acquisition of Business
Sale of Business
Sale/Maturity of Investment
Purchase of Investments
Other Investing Cash Flow
Cash from Investing Activities-1,438-608-563-245-209
Financing Cash Flow Items-40.6-48.6-11.6-43.4-55
Other Financing Cash Flow
Net Issuance / Retirement of Stock
Net Issuance / Retirement of Debt
Cash from Financing Activities673-42.4-85.5-551-537
Foreign Exchange Effects
Beginning Cash Balance
Ending Cash Balance
Net Change in Cash13.2-5.143.3-78.910.4